drugset / Trial / NCT03926663

Intranasal Injection of Dexmedetomidine and Bupivacaine in Septoplasty Surgeries

NCT03926663 ↗

Phase 4 Unknown 40 enrolled Cairo University
RandomizedParallel-groupTriple-blindSupportive care

Summary

Pain is particularly common after nasal surgery, especially when bone manipulation and periosteal irritation are involved. Appropriate pain control is an important consideration in the post-surgical management of patients.

Timeline

Start
2019-07-20
Primary completion
2019-09
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 1 mg/kg Intranasal
Subject Bupivacaine Other / unclassified 1.5 mg/kg Intranasal
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg Intranasal

Indications

No indication recorded.